FRA:2HRA - Deutsche Boerse Ag - DE000A2E4T77 - Common Stock - Currency: EUR
FRA:2HRA (3/7/2025, 7:00:00 PM)
4
0 (0%)
The current stock price of 2HRA.DE is 4 EUR. In the past month the price increased by 7.53%. In the past year, price decreased by -20.63%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
6D81.DE | DUPONT DE NEMOURS INC | 19.09 | 29.92B | ||
DSFIR.AS | DSM-FIRMENICH AG | 10.51 | 25.51B | ||
BRG.OL | BORREGAARD ASA | 21.84 | 18.00B | ||
ELK.OL | ELKEM ASA | 29.74 | 14.84B | ||
SY1.DE | SYMRISE AG | 34.09 | 13.39B | ||
1COV.DE | COVESTRO AG | N/A | 11.08B | ||
AKZA.AS | AKZO NOBEL N.V. | 15.78 | 10.49B | ||
EVK.DE | EVONIK INDUSTRIES AG | 27.39 | 10.08B | ||
AMC.DE | ALBEMARLE CORP | N/A | 8.33B | ||
SYENS.BR | SYENSQO SA | N/A | 7.47B | ||
AKE.PA | ARKEMA | 10.06 | 6.30B | ||
WCH.DE | WACKER CHEMIE AG | 30.92 | 4.02B |
H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. The company is headquartered in Salzbergen, Niedersachsen and currently employs 1,697 full-time employees. The company operates through three segments: Chemical-Pharmaceutical Raw Materials Refining (ChemPharm Refining), Chemical-Pharmaceutical Raw Materials Sales (ChemPharm Sales) and Plastics. The ChemPharm Refining segment comprises two refineries in Germany, which produce plasticizers, paraffins, white oils and base oils; the ChemPharm Sales segment includes production and distribution sites worldwide and its main products are label-free plasticizers for the tire industry, as well as paraffins for various applications, and the Plastics segment produces precision plastic parts and molding tools to manufacture precision plastic parts.
H&R GMBH & CO KGAA
Neuenkirchener Str. 8
Salzbergen NIEDERSACHSEN DE
Employees: 1658
Company Website: https://www.hur.com/
Investor Relations: http://www.hur.com/en/investor-relations
Phone: 4959769450
The current stock price of 2HRA.DE is 4 EUR.
The exchange symbol of H&R GMBH & CO KGAA is 2HRA and it is listed on the Deutsche Boerse Ag exchange.
2HRA.DE stock is listed on the Deutsche Boerse Ag exchange.
8 analysts have analysed 2HRA.DE and the average price target is 6.43 EUR. This implies a price increase of 60.65% is expected in the next year compared to the current price of 4. Check the H&R GMBH & CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
H&R GMBH & CO KGAA (2HRA.DE) has a market capitalization of 148.88M EUR. This makes 2HRA.DE a Micro Cap stock.
H&R GMBH & CO KGAA (2HRA.DE) currently has 1658 employees.
H&R GMBH & CO KGAA (2HRA.DE) has a support level at 3.73 and a resistance level at 4.22. Check the full technical report for a detailed analysis of 2HRA.DE support and resistance levels.
The Revenue of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -6.53% in the next year. Check the estimates tab for more information on the 2HRA.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
H&R GMBH & CO KGAA (2HRA.DE) has a dividend yield of 2.5%. The yearly dividend amount is currently 0.1. Check the full fundamental report for a detailed analysis of 2HRA.DE dividend history, reliability and sustainability.
H&R GMBH & CO KGAA (2HRA.DE) will report earnings on 2025-03-26, after the market close.
The PE ratio for H&R GMBH & CO KGAA (2HRA.DE) is 28.57. This is based on the reported non-GAAP earnings per share of 0.14 and the current share price of 4 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 2HRA.DE.
ChartMill assigns a technical rating of 6 / 10 to 2HRA.DE. When comparing the yearly performance of all stocks, 2HRA.DE is a bad performer in the overall market: 69.29% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to 2HRA.DE. 2HRA.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months 2HRA.DE reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS decreased by -60.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.42% | ||
ROA | 0.59% | ||
ROE | 1.31% | ||
Debt/Equity | 0.21 |
ChartMill assigns a Buy % Consensus number of 80% to 2HRA.DE. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -54.55% and a revenue growth -6.53% for 2HRA.DE